Stock data
TherapeuticsMD, Inc. (TXMD)
TherapeuticsMD, Inc. (TXMD) reported net income of -US$0.57M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$4.39M | -US$0.57M | — |
| 2024 | US$1.76M | — | -US$6.11M | -US$2.18M | — |
| 2023 | US$1.30M | US$1.30M | -US$8.52M | -US$10.28M | — |
| 2022 | US$69.96M | US$68.57M | US$1.19M | US$112.00M | — |
| 2021 | US$2.57M | US$1.17M | -US$79.58M | -US$172.41M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | US$0.15M | — |
| 2026-03-31 | US$0.72M | US$0.10M | — |
| 2025-12-31 | — | -US$0.62M | — |
| 2025-09-30 | — | US$0.15M | — |
| 2025-06-30 | — | US$0.55M | — |
| 2025-03-31 | US$0.39M | -US$0.65M | — |
| 2024-12-31 | — | US$0.25M | — |
| 2024-09-30 | — | -US$0.61M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.